Joseph Pitts actually said...

Could legislation that applies different standards adversely affect the quality of drugs made available to patients?

Hasn't the FDA recently used its manufacturing inspection authority to inspect manufacturers acting under the guise of compounding recently?

I urge the subcommittee to make sure we get this proposal right and that we work together to get there.

Will national uniformity increase the security of the supply chain and improve patient safety?